Black Rock Inc. Sellas Life Sciences Group, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 430,368 shares of SLS stock, worth $525,048. This represents 0.0% of its overall portfolio holdings.
Number of Shares
430,368
Previous 278,218
54.69%
Holding current value
$525,048
Previous $281,000
82.21%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SLS
# of Institutions
39Shares Held
5.69MCall Options Held
1.67MPut Options Held
74.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.8 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX794KShares$968,4780.12% of portfolio
-
Geode Capital Management, LLC Boston, MA605KShares$738,3330.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$376,3283.71% of portfolio
-
Opus Capital Group, LLC226KShares$275,8420.04% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $25.1M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...